Genomic Precision

 A SeraCare blog focused on precision medicine and advanced clinical diagnostics

NTRK Fusion Testing for New Therapies

Detecting & Managing Rare Pediatric & Adult Cancers

Posted by Omo Clement, Ph.D. on Feb 6, 2019 9:15:00 AM

Neurotrophic tyrosine receptor kinases (NTRK) can become abnormally fused to other genes resulting in growth signals that can lead to cancer in many organs of the human body. TRK gene fusion-based cancers are rare but present in pediatric and adult cancers such as lung, thyroid, colon, etc. (see, e.g., Figure 1).

Read More

Topics: Lung Cancer, colon cancer, NTRK, RNA fusion

 
 
ebook CTA image square Jan2019

Subscribe for Updates

Recent Posts

Categories

see all